These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24138005)

  • 1. The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst.
    Xie RF; Hu P; Li W; Ren YN; Yang J; Yang YM; Wang ZY; Fan HH
    Vox Sang; 2014 Apr; 106(3):234-41. PubMed ID: 24138005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular endothelial cells.
    Xie RF; Hu P; Wang ZC; Yang J; Yang YM; Gao L; Fan HH; Zhu YM
    Transfusion; 2015 May; 55(5):1051-7. PubMed ID: 25565376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance.
    Bercovitz RS; Kelher MR; Khan SY; Land KJ; Berry TH; Silliman CC
    Vox Sang; 2012 May; 102(4):345-53. PubMed ID: 22092073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microparticles in red cell concentrates prime polymorphonuclear neutrophils and cause acute lung injury in a two-event mouse model.
    Xie R; Yang Y; Zhu Y; Gao L; Jiang X; Sun J; Bian M; Yang J
    Int Immunopharmacol; 2018 Feb; 55():98-104. PubMed ID: 29241160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates.
    Wenzel F; Günther W; Baertl A; Lasshofer R; Rox J; Fischer JC; Giers G
    Clin Hemorheol Microcirc; 2011; 47(4):269-78. PubMed ID: 21654056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury.
    Khan SY; Kelher MR; Heal JM; Blumberg N; Boshkov LK; Phipps R; Gettings KF; McLaughlin NJ; Silliman CC
    Blood; 2006 Oct; 108(7):2455-62. PubMed ID: 16772606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of apheresis, storage time, and leukofiltration on microparticle formation in apheresis platelet products.
    Gao M; Zhang B; Zhang Y; Chen Y; Xiong J; Wang J; Chen H; Chen G; Wei Q
    Transfusion; 2018 Oct; 58(10):2388-2394. PubMed ID: 30203553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of CD62P during storage of apheresis platelet concentrates and the role of CD62P in transfusion-related acute lung injury.
    Tong S; Wang H; Zhang T; Chen L; Liu B
    Mol Med Rep; 2015 Nov; 12(5):7777-81. PubMed ID: 26397744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of leucocyte antibodies, cytokines, lysophospholipids and cell microparticles in blood components implicated in post-transfusion reactions with dyspnoea.
    Maślanka K; Uhrynowska M; Łopacz P; Wróbel A; Smoleńska-Sym G; Guz K; Lachert E; Ostas A; Brojer E
    Vox Sang; 2015 Jan; 108(1):27-36. PubMed ID: 25134637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury.
    Tuinman PR; Gerards MC; Jongsma G; Vlaar AP; Boon L; Juffermans NP
    Clin Exp Immunol; 2011 Aug; 165(2):278-84. PubMed ID: 21605114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions.
    Blumberg N; Gettings KF; Turner C; Heal JM; Phipps RP
    Transfusion; 2006 Oct; 46(10):1813-21. PubMed ID: 17002639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the platelet washing process on in vitro platelet properties, and the levels of soluble CD40 ligand and platelet-derived microparticles in the storage media.
    Oikawa S; Minegishi M; Endo K; Kawashima W; Kosunago S; Oyama M; Suzuki K; Shimizu H
    Transfusion; 2019 Mar; 59(3):1080-1089. PubMed ID: 30588642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion.
    Kaufman J; Spinelli SL; Schultz E; Blumberg N; Phipps RP
    J Thromb Haemost; 2007 Apr; 5(4):788-96. PubMed ID: 17403203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet transfusion alters CD40L blood level and release capacity in patients suffering from thrombocytopenia.
    Wenzel F; Günther W; Baertl A; Gruber W; Sorg RV; Haas R; Giers G
    Transfusion; 2012 Jun; 52(6):1213-20. PubMed ID: 22082313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model.
    Kelher MR; Banerjee A; Gamboni F; Anderson C; Silliman CC
    Transfusion; 2016 Dec; 56(12):3004-3011. PubMed ID: 27667662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of potential immunomodulatory factors during platelet storage.
    Cognasse F; Boussoulade F; Chavarin P; Acquart S; Fabrigli P; Lamy B; Garraud O
    Transfusion; 2006 Jul; 46(7):1184-9. PubMed ID: 16836566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric detection of circulating platelet-derived microparticles in healthy adult horses.
    Springer NL; Smith E; Brooks MB; Stokol T
    Am J Vet Res; 2014 Oct; 75(10):879-85. PubMed ID: 25255176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
    Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
    Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.